Download PDF
Nuklearmedizin 2018; 57(06): N57
DOI: 10.3413/Nukmed-0990-18-08
Case Report
Georg Thieme Verlag KG Stuttgart · New York

HCG-induced hyperthyroidism in a 51-year-old patient with hydatidiform mole

Justus Baumgarten
1   Universitätsklinikum Frankfurt; Klinik für Nuklearmedizin
,
Christian Happel
1   Universitätsklinikum Frankfurt; Klinik für Nuklearmedizin
,
Sven Becker
2   Universitätsklinikum Frankfurt; Klinik für Frauenheilkunde und Geburtshilfe
,
Ahmed El-Balat
2   Universitätsklinikum Frankfurt; Klinik für Frauenheilkunde und Geburtshilfe
,
Frank Grünwald
1   Universitätsklinikum Frankfurt; Klinik für Nuklearmedizin
› Author Affiliations
Further Information

Publication History

Received: 06 August 2018

accepted: 10 October 2018

Publication Date:
18 December 2018 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Canfield RE, O’Connor JF, Birken S, Krichevsky A, Wilcox AJ. Development of an assay for a biomarker of pregnancy and early fetal loss. Environ Health Perspect 1987; 74: 57-66.
    CrossrefPubMedGoogle Scholar
  • 2 Ghaemmaghami F, Ashraf-Ganjooie T. Gestational trophoblastic neoplasia. Asia-Pacific Journal of Clinical Oncology 2006; 02 (01) 9-21.
    Google Scholar
  • 3 Giralt S, Dexeus F, Amato R. Hyperthyroidism in men with germ cell tumours and high levels of beta-human chorionic gonadotropin. Cancer 1992; 69: 1286-1290.
    PubMedGoogle Scholar
  • 4 Yoshimura M, Pekary AE, Pang XP, Berg L, Goodwin TM, Hershman JM. Thyrotropic activity of basic isoelectric forms of human chorionic gonadotropin extracted from hydatidiform mole tissues. J Clin Endocrinol Metab 1994; 78 (04) 862-866.
    PubMedGoogle Scholar